Uveitis in child treated for acute myeloblastic leukemia: Do not overlook poststreptococcal inflammation

Philippe Gardeton1, Inés Chabbi2, Margaux Camuset1

  • 1Pediatric Oncology and Hematology, Nantes University Hospital, Nantes, France.

PubMed

Insights

Post-Streptococcus mitis uveitis is a rare immune complication. This case highlights its potential misdiagnosis in leukemia patients undergoing chemotherapy, emphasizing the need for consideration despite neutropenia.

Area of Science:

  • Ophthalmology
  • Infectious Diseases
  • Hematology

Background:

  • Post-streptococcal uveitis is a known immune complication of streptococcal infections.
  • Acute myeloblastic leukemia (AML) treatment involves chemotherapy, which can cause immunosuppression and febrile neutropenia.
  • Cytarabine is a common chemotherapeutic agent used in AML treatment.